Herremans; Arnoldus H. J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herremans; Arnoldus H. J..The latest application filed is for "muscarinic agonists to treat impulse control disorders".

Company Profile

0.8.11

Herremans; Arnoldus H. J. - Weesp NL
Herremans, Arnoldus H J - Weesp NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1H-imidazole derivative having CB.sub.1, agonistic, CB.sub.1 partial agonistic or CB.sub.1 antagnistic activity Grant 8,729,101 - Kruse , et al. May 20, 2	2014-05-20
Muscarinic Agonists To Treat Impulse Control Disorders App 20100120752 - De Bruin; Natasja M.W.J. ; et al.	2010-05-13
4,5-dihydro-1H-pyrazole derivatives having potent CB.sub.1-antagonistic activity Grant 7,608,718 - Lange , et al. October 27, 2	2009-10-27
1h-imidazole Derivative Having Cb1, Agonistic, Cb1 Partial Agonistic Or Cb1 Antagnistic Activity App 20090181949 - KRUSE; Cornelis G. ; et al.	2009-07-16
4,5-dihydro-1H-pyrazole derivatives having CB.sub.1-antagonistic activity Grant 7,528,162 - Kruse , et al. May 5, 2	2009-05-05
Use Of 5-ht6 Antagonists To Prevent Relapse Into Addiction App 20080171779 - De Bruin; Natasja M.W.J. ; et al.	2008-07-17
Thiazole derivatives having CB.sub.1-antagonistic, agonistic or partial agonistic activity Grant 7,342,032 - Lange , et al. March 11, 2	2008-03-11
N-oxides Of Pyridylmethyl -piperazine And -piperidine Derivatives App 20070275977 - Van Aar; Marcel P.M. ; et al.	2007-11-29
Muscarinic Agonists To Treat Impulse Control Disorders App 20070259859 - De Bruin; Natasja M.W.J. ; et al.	2007-11-08
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity App 20070259884 - Lange; Josephus H.M. ; et al.	2007-11-08
1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity Grant 7,109,216 - Kruse , et al. September 19, 2	2006-09-19
Piperazine oxime dervatives having NK-1 receptor antagonistic activity Grant 7,094,779 - Bakker , et al. August 22, 2	2006-08-22
4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity Grant 6,974,810 - Lange , et al. December 13, 2	2005-12-13
1 H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity App 20050054679 - Kruse, Cornelis G. ; et al.	2005-03-10
Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity App 20040266841 - Lange, Josephus H.M. ; et al.	2004-12-30
Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity App 20040248944 - Kruse, Cornelis G ; et al.	2004-12-09
1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity App 20040235854 - Kruse, Cornelis G. ; et al.	2004-11-25
Piperazine oxime dervatives having nk-1 receptor antagonistic activity App 20040176389 - Bakker, Wouter I Ivema ; et al.	2004-09-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.